...
首页> 外文期刊>The British journal of occupational therapy >Examining a new functional electrical stimulation therapy with people with severe upper extremity hemiparesis and chronic stroke: A feasibility study
【24h】

Examining a new functional electrical stimulation therapy with people with severe upper extremity hemiparesis and chronic stroke: A feasibility study

机译:用严重的上肢血征和慢性中风的人检查新的功能性电刺激治疗:可行性研究

获取原文
获取原文并翻译 | 示例

摘要

Introduction Upper extremity impairment post-stroke is common and results in decreased occupational engagement. For those with chronic stroke and severe hemiparesis, few treatment options are available. MyndMove? is a functional electrical stimulation technology programmed to stimulate up to eight muscle groups in reach and grip patterns. A pre–post, cohort, feasibility study was conducted to inform the design of a randomized controlled trial examining the effectiveness of MyndMove? therapy. Method Individuals enrolled had chronic severe upper extremity hemiparesis following a stroke (> 6 months) with Chedoke-McMaster Stroke Assessment Stage 1–2 (arm and hand) and a Fugl-Meyer Upper Extremity score less than 19. Treatment with Myndmove?, consisting of 20 one-hour sessions, 3–5 times per week over 4–6 weeks was provided. Results Of 25 enrolled participants, 24 (96%) completed treatment. Fifty-eight percent (14/24) of the participants demonstrated improvement equal to or exceeding the minimal clinically important difference of five on the Fugl-Meyer Upper Extremity test. Mean change from baseline Fugl-Meyer Upper Extremity overall score was 7.1 (SD 5.0) ( p ? Conclusion MyndMove? therapy is feasible to deliver within outpatient settings and may be a suitable function-based treatment option for severe chronic stroke upper extremity impairment. ]]>
机译:引言上肢损伤后障碍是常见的,导致职业接触减少。对于患有慢性卒中和严重血清的人,可以使用很少的治疗选择。 myndmove?是一个功能性电刺激技术,用于刺激到达八个肌肉群的伸展和握持模式。举行职位前,队列,可行性研究,以告知审查MyNDMove的有效性的随机对照试验的设计?治疗。在中风(> 6个月)后,纳入的方法患有慢性严重的上肢血管血管术,Chedoke-McMaster中风评估阶段1-2(手臂和手)和Fugl-Meyer上肢得分小于19.用MyndMove治疗组成为期20个小时,每周3-5次提供4-6周。结果25名参与者,24名(96%)完成治疗。参与者58%(14/24)人表现出平等或超过Fugl-Meyer上肢测试的最小临床重要差异的改善。从基线Fugl-Meyer上肢的平均变化总体分数为7.1(SD 5.0)(P?结论MyndMove?治疗是可行的,可以在门诊环境中提供,并且可能是严重慢性冲程上肢损伤的合适功能的治疗选择。] ]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号